World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.
Asymmetric Synthesis of 3,3-Disubstituted Oxindoles cover
Also available at Amazon and Kobo

 

Indole derivatives are the most common heterocycle compounds present in nature, for this reason, they have been referred to as "privileged structures". In fact, many approved drugs — and natural products — belong to this family. Among indole derivatives, oxindoles have a structural complexity, which have stimulated generations of synthetic chemists to design strategies for assembling these structures, and their enantioselective synthesis is still growing.

This book proposes to describe the known enantioselective syntheses of oxindole derivatives. It is divided in six chapters each referring to a specific class of asymmetric oxindole derivatives. After the introduction, Chapter 2 describes all-carbon spirooxindoles; Chapter 3, open chain 3,3-dialkyloxindoles; Chapter 4, 3-substituted-3-aminooxindoles; Chapter 5, 3-substituted-3-hydroxyoxindoles; Chapter 6, 3-hetero-3-substituted oxindoles. It will be a useful tool for synthetic chemists, who assemble total synthesis of natural products, as well as for drug discovery chemists either in academic or in industry R&S laboratories.

 

Sample Chapter(s)
Preface
Chapter 1: Introduction

 

Contents:

  • Introduction
  • All-Carbon Spirooxindoles
  • Open Chain 3,3-Dialkyloxindoles
  • Catalytic Asymmetric Synthesis of 3-Substituted-3-Amino-2-Oxindoles
  • Enantioselective Synthesis of 3-Substituted-3-Hydroxyoxindoles
  • 3-Hetero-3-Substituted Oxindoles

 

Readership: Academic and pharmaceutic industry researchers.